Navigation Links
Former Capital One Director and Business Leader Stanley I. Westreich Joins Neuralstem's Board
Date:2/15/2011

he ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells constitutively into mature, physiologically relevant human neurons and glia. Neuralstem is in a FDA-approved Phase I safety clinical trial for amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig's disease and has been awarded orphan status designation by the FDA.

In addition to ALS, the company is also targeting major central nervous system diseases, including traumatic spinal cord injury, ischemic spastic paraplegia, and Huntington's disease. The company has also submitted an IND (Investigational New Drug) application to the FDA for a Phase I safety trial in chronic spinal cord injury.

Neuralstem also has the ability to generate stable human neural stem cell lines suitable for the systematic screening of large chemical libraries. Through this proprietary screening technology, Neuralstem has discovered and patented compounds that may stimulate the brain's capacity to generate new neurons, possibly reversing the pathologies of some central nervous system conditions.  The company has been approved to commence a Phase Ia safety trial evaluating NSI-189, its first small molecule compound, for the treatment of major depression.  Additional indications could include schizophrenia, Alzheimer's disease, traumatic brain injury, posttraumatic stress syndrome, and stroke.

For more information, please go to www.neuralstem.com.

Cautionary Statement Regarding Forward Looking Information

This news release may contain forward-looking statements made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements in this press release regarding potential applications of Neuralstem's technologies constitute forward-look
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Former Cerner Chief Operating Officer Joins Netsmart Technologies Board of Directors
2. Former U.S. Congressman Curt Weldon to Represent Regenicin at 2011 Future of Financial Markets Conference in Mumbai
3. Edwin Rivera-Martinez, Former Chief of the FDA’s International Compliance Branch, Joins PAREXEL Consulting Strategic Compliance Team
4. Former FDA Inspectors Train Medical Device, Pharmaceutical Companies How to Comply with Latest FDA Expectations for Validation and Part 11
5. Heiner Dreismann, Ph.D., Former President of Roche Molecular Systems, Joins the HistoRx Board of Directors
6. Regenicin Names Former U.S. Marine Corp Operations Officer, Christopher Hadsall, Chief Operating Officer
7. Dismissal of Lawsuit by Former Officer Affirmed by Appellate Court
8. Former Fujifilm Medical Systems USA Executive John J. Weber Agrees to Join Regenicin™ as a Member of Its Board of Directors and Interim CFO
9. UPDATE: Appeal of Lawsuit by Former Chief Executive Officer- Reinstated; and Sanctions Order Vacated
10. Appeal of Lawsuit by Former Chief Executive Officer- Reinstated; and Sanctions Order Vacated
11. Axial Exchange Recruits Karen Evans, Former Fed CIO, to Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... 26, 2014 Vycom announced today that ... specializes in chemical process equipment, has selected its Flametec ... Facility for Rare Isotope Beams (FRIB). This involved ... line made with Vycom’s Flametec PVC-C and Kytec PVDF ... essential parts of FRIB’s linear accelerator (known as LINAC). ...
(Date:8/26/2014)... 2014 Trovagene, Inc. (NASDAQ:  TROV) presented ... Moving Assays to the Clinic with an ... Cell Free Tumor DNA in Urine." In this ... Precision Cancer Monitoring (PCM) platform and results from ... detection of tumor DNA mutations from urine samples ...
(Date:8/26/2014)... , Aug. 26, 2014  Guardant Health, a ... of oncology diagnostic products, has been recognized today ... Technology Pioneer . As an innovator in ... 24 companies across a wide variety of industries ... Guardant360 ® , Guardant Health,s first ...
(Date:8/26/2014)... , Aug. 26, 2014 Albany Molecular ... that William S. Marth , President and Chief ... Stanley Global Healthcare Conference on Monday, September 8, 2014 ... audio webcast of the presentation can be accessed at ... The webcast will be archived for 90 ...
Breaking Biology Technology:Modutek Selects Vycom’s Flametec Materials for Michigan State University’s Superconductor Equipment 2Modutek Selects Vycom’s Flametec Materials for Michigan State University’s Superconductor Equipment 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 4Guardant Health Named a 2015 Technology Pioneer by World Economic Forum 2
... Pipeline-Grade Renewable Natural Gas ... Manure and Other Waste Products, TARRYTOWN, N.Y., June ... leader in the renewable bioenergy industry,will today mark the ... with a ground breaking ceremony. The Dublin, Texas,facility, owned ...
... for,Analytical Cytometry has bestowed its President,s Award for ... work on the discovery and,characterization of embryonic-like stem ... Institute of the University of Louisville and has,employed ... "I am highly honored to have been ...
... WA, June 11 /PRNewswire-FirstCall/ - Oncothyreon Inc.,(Nasdaq: ... that the first,patient has been treated in a ... advanced metastatic cancer. PX-12 is a proprietary small ... molecular,pathways that contribute to the growth, survival and ...
Cached Biology Technology:Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates 2Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates 3Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates 4Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates 5Stem Cell Researcher Wins Award for Excellence for Work With the ImageStream(R) System 2Oncothyreon initiates Phase 1b trial of PX-12 in patients with advanced metastatic cancer 2Oncothyreon initiates Phase 1b trial of PX-12 in patients with advanced metastatic cancer 3
(Date:8/26/2014)... are bringing a touch of color to glucose ... glucose monitoring material that changes color as glucose ... precise that doctors and patients may be able ... - something not possible using current point measurements ... to current continuous glucose monitoring technologies," said study ...
(Date:8/26/2014)... at the University of Illinois at Urbana-Champaign have ... paving the way for power-on-a-chip applications. , ... scale that amplify light and produce ultra-narrowband spectral ... electrical and computer engineering (ECE) at Illinois. "These ... power on a chip containing both electronic and ...
(Date:8/26/2014)... , August 26, 2014 ... Veröffentlichung von Oxygen Forensic Passware Analyst bekannt, ... die preisgekrönten Erfassungs- und Analysetools von Oxygen ... kombiniert.     Das neue Tool ... in einem einzigen nahtlosen Ablauf. Das neu ...
Breaking Biology News(10 mins):A glucose meter of a different color provides continuous monitoring 2A glucose meter of a different color provides continuous monitoring 3Symphony of nanoplasmonic and optical resonators produces laser-like light emission 2Oxygen Forensic Passware Analyst erfasst geschützte Mobilgerätedaten 2
... report describing the occurrence of pesticides in streams and ... are typically present throughout the year in most streams ... are less common in ground water. The report ... to affect humans. However in many streams, particularly ...
... a heart attack does not improve certain cardiac functions ... risk of death, according to a study in the ... widely available dietary supplement and is publicized as having ... sexual dysfunction, according to background information in the article. ...
... L-arginine following a heart attack does not improve certain ... an increased risk of death, according to a study ... is a widely available dietary supplement and is publicized ... failure and sexual dysfunction, according to background information in ...
Cached Biology News:Pesticides in the nation's streams and ground water 2Pesticides in the nation's streams and ground water 3Pesticides in the nation's streams and ground water 4An elephant tail 2Little known DNA repair enzyme may be a tumor suppressor gene 2
... Clear yellow solution. In ... thimerosal, and other proprietary ... Diluent formulated to stabilize ... antibody conjugates at high ...
... software is used to predict ... DNA sequence up to 3,200 ... placement of primers and GC ... denaturing gradient gel electrophoresis (DGGE), ...
... The Mini-Sub cell GT cell and PowerPac ... gel electrophoresis of nucleic acids in agarose gels. ... tank, lid with cables and electrodes, a 7 ... ruler, two casting gates, and two 1.5 mm ...
... PowerPac basic power supply are used for submerged ... gels. The mini format cell includes a buffer ... bubble. The PowerPac basic power supply, 100-120 and ... mA, and 75 W. Power cord and instructions ...
Biology Products: